Mérieux Développement is expanding its activities by creating a second evergreen vehicle, with a total commitment of EUR150 million sponsored by Institut Mérieux.
As part of a long-term partnership agreement, Sienna Capital, a company controlled by Groupe Bruxelles Lambert (GBL), has committed an initial amount of EUR75 million, mostly dedicated to the new vehicle established.
Mérieux Développement will deploy substantial new capital within the healthcare and nutrition sectors in growth capital as well as venture capital. To support this expansion, Mérieux Développement recently opened permanent offices in the US and appointed Christine Demode as chief financial officer.
“We are very honoured to partner with the alternative investment holding of GBL, anchored by the Canadian Desmarais and Belgian Frère families who are highly reputable and long term investors in the industrial sector. The renewed commitment of Institut Merieux and the support of GBL underline the quality of the performance achieved by the team since 2010 and the pertinence of our investment approach,” says Alexandre Mérieux, president of Mérieux Développement.
Colin Hall, CEO of Sienna Capital, says: "I am impressed by the team at Mérieux Développement and the portfolio they have constructed. We are glad to be their partner as they continue building a best-in-class healthcare investment firm."
